SynthesisFrontiers in neurology2021

Clinical and Paraclinical Biomarkers and the Hitches to Assess Conversion to Secondary Progressive Multiple Sclerosis: A Systematic Review.

Nik Krajnc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.